Streetbeat News

Stock Prices

WPM

Wheaton Precious Metals (NYSE:WPM) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $0.27. The company's stock price often reacts more to the guidance provided than the earnings beat or miss. Last quarter, the company missed EPS by $0.02, resulting in a 1.32% increase in the share price the next day. The stock is currently trading at $43.75 and has seen a 30.71% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:01 pm

FLYW

Flywire (NASDAQ:FLYW) has received 9 analyst ratings in the last quarter, with 8 being bullish or somewhat bullish and 1 being indifferent. The average price target is $37.78, which is higher than the current price of $35.08, implying an upside. The average price target has increased by 9.51% over the past month.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:01 pm

ALDX

Aldeyra Therapeutics (NASDAQ:ALDX) has received 5 analyst ratings in the last quarter, with 4 being bullish and 1 somewhat bullish. The average price target is $16.8, indicating an upside from the current price of $7.4899. However, this average has decreased by 40.0% from the previous average price target of $28.00.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm

ADTN

Over the past 3 months, 6 analysts have published their opinion on Adtran (NASDAQ:ADTN) stock, all of them being bullish. The average price target is $13.5, implying an upside from the current price of $7.35. This average represents a 28.95% decrease from the previous average price target of $19.00.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm

UBX

Over the past 3 months, 4 analysts have published their opinion on Unity Biotechnology (NASDAQ:UBX) stock. The average price target is $7.0, implying an upside from the current price of $2.41. The average price target has increased by 75.0% over the past month.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm

RAPT

In the last quarter, RAPT Therapeutics (NASDAQ:RAPT) received 3 bullish and 1 somewhat bullish ratings from analysts. The average 12-month price target for the company is $39.25, representing an 8.72% decrease from the previous average price target of $43.00.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm

UNH

UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 10 years by 11.05% on an annualized basis, producing an average annual return of 21.26%. If an investor had bought $100 of UNH stock 10 years ago, it would be worth $696.50 today.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm

TNGX

Shares of Tango Therapeutics (TNGX) were halted on a circuit breaker due to a significant upside movement. The stock is now up by 136.8%.

Portfolio Pulse from Happy Mohamed

August 09, 2023 | 2:00 pm

DUOL

Analysts have provided bullish ratings for Duolingo (NASDAQ:DUOL) in the last quarter, with 2 bullish and 1 somewhat bullish ratings. The company has an average 12-month price target of $163.33, a 2.2% decrease from the previous average price target of $167.00.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm

ABBV

Over the past 10 years, AbbVie (NYSE:ABBV) has outperformed the market by 2.69% on an annualized basis, producing an average annual return of 12.89%. If an investor had bought $100 of ABBV stock 10 years ago, it would be worth $335.41 today.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm